IRIS
CLEMENTI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.544
NA - Nord America 1.276
AS - Asia 142
OC - Oceania 5
SA - Sud America 5
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.976
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.268
SE - Svezia 1.056
IT - Italia 280
FI - Finlandia 73
CN - Cina 68
IE - Irlanda 49
DE - Germania 40
IN - India 34
SG - Singapore 19
RU - Federazione Russa 13
RO - Romania 9
CA - Canada 8
SA - Arabia Saudita 6
FR - Francia 5
GB - Regno Unito 5
HU - Ungheria 5
NL - Olanda 5
PH - Filippine 5
AU - Australia 4
CL - Cile 4
IR - Iran 4
BE - Belgio 2
HK - Hong Kong 2
JP - Giappone 2
TN - Tunisia 2
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 2.976
Salva come PNG Salva come JPEG
Città #
Princeton 359
Lawrence 356
Ashburn 164
Milan 143
New York 101
Helsinki 73
Shanghai 61
Dublin 46
Pune 33
Seattle 23
Washington 20
Bologna 17
Rome 17
Los Angeles 11
Borås 10
Budapest 5
Jeddah 5
Turin 5
Vittoria 5
Ancona 4
Hanover 4
London 4
Quezon City 4
Santiago 4
St Petersburg 4
Angera 3
Ballincollig 3
Busto Arsizio 3
Frankfurt Am Main 3
Gatchina 3
Melbourne 3
Riccione 3
Rockville 3
Segrate 3
Southend-on-sea 3
Toronto 3
Varese 3
Albano Laziale 2
Como 2
Ghent 2
Kunming 2
Las Vegas 2
Littleton 2
Magdeburg 2
Naaldwijk 2
Naples 2
Napoli 2
Omsk 2
Padova 2
Paris 2
Shenzhen 2
Singapore 2
Torre Del Greco 2
Vaprio d'Adda 2
Verona 2
Amsterdam 1
Bacoor 1
Bari 1
Beijing 1
Bloemfontein 1
Buffalo 1
Cagliari 1
Central 1
Dresano 1
Falkenstein 1
Falls Church 1
Guangzhou 1
Hamilton 1
Henderson 1
Isfahan 1
Karachi 1
Kuala Lumpur 1
Kwai Chung 1
Lainate 1
Lansing 1
Metairie 1
Mountain View 1
Nardò 1
Paliano 1
Pavia 1
Perm 1
Providence 1
Reggio Calabria 1
Riverside 1
Riyadh 1
Rotterdam 1
San Diego 1
San Sperate 1
Santa Clara 1
Secaucus 1
Sheffield 1
Sydney 1
São Paulo 1
Tehran 1
Teramo 1
Tokyo 1
Vigevano 1
Volgograd 1
Wellington 1
Winnipeg 1
Totale 1.595
Salva come PNG Salva come JPEG
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 41
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 35
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 30
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 29
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 27
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 27
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 25
Biobanking for COVID-19 research 25
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 25
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 24
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 23
A Biologically-validated HCV E1E2 Heterodimer Structural Model 23
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 22
Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo 22
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 22
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 21
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 21
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 20
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 19
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 19
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 19
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 19
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 18
2-Aminothiazolones as Anti-HIV Agents That Act as gp120-CD4 Inhibitors 18
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 18
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 18
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 18
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 18
A SINGLE-STEP DNA EXTRACTION PROCEDURE FOR THE DETECTION OF SERUM HEPATITIS-B VIRUS SEQUENCES BY THE POLYMERASE CHAIN-REACTION 17
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 17
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 17
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 17
Viral Respiratory Pathogens and Lung Injury 17
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 17
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 16
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 16
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 16
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 16
Laparoscopic right hemicolectomy: the SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie) network prospective trial on 1225 cases comparing intra corporeal versus extra corporeal ileo-colic side-to-side anastomosis 16
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 16
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 16
The interferon landscape along the respiratory tract impacts the severity of COVID-19 16
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 15
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 15
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 15
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 15
A NOVEL PROCEDURE FOR QUANTITATIVE POLYMERASE CHAIN-REACTION BY COAMPLIFICATION OF COMPETITIVE TEMPLATES 15
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 15
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 15
Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen 15
IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation 15
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 15
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection 15
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 15
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 14
GB Virus C and Survival in Persons with HIV Infection 14
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 14
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 14
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients 14
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 14
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 14
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 13
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 13
Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL 13
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 13
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 13
Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections 13
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 13
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome 13
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 13
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 13
Steps and routes of HCV infection: The great promise of new anti-viral targets 13
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 13
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 13
HEFFICON: HIV Effectiveness Italian Conference 13
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 13
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 12
A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection 12
Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir 12
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 12
HCV E2 core structures and mAbs: something is still missing 12
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis 12
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 12
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 12
Role and potential therapeutic use of antibodies against herpetic infections 12
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 12
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial 12
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 12
Protocols and self-checking plans for the safety of post-covid-19 balneotherapy 12
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 11
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 11
An improved phage display vector for antibody repertoire cloning by construction of combinatorial libraries 11
Duodenal mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota 11
Human monoclonal recombinant antibody against NS3 HCV protein and methods therefor 11
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 11
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 10
COAMPLIFICATION OF TRANSCRIPTIONALLY ACTIVE EPIDERMAL GROWTH-FACTOR RECEPTOR AND RIBOSOMAL GENES IN THE HUMAN HEPATOMA-CELL LINE LI7A 10
Intracellular expression of recombinant human immunoglobulin (IGGI) against NS3 inhibits helicase activity and HCV replication in cell culture 10
Treatment of SARS with human interferons 10
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 10
Totale 1.621
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 5 0 0
2019/202021 14 0 0 0 0 0 4 0 0 0 0 3
2020/202177 5 1 1 8 6 15 17 13 1 7 2 1
2021/2022232 6 3 20 72 19 18 15 15 12 18 8 26
2022/20231.989 811 463 167 18 26 224 71 112 71 5 13 8
2023/2024753 21 44 151 95 68 228 22 79 5 40 0 0
Totale 3.239